Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rhinovirus capsid protein VP1 plays essential roles both structurally—as part of an organized shell protecting viral RNA—and functionally—in determining host range via specific interactions with cellular receptors. Its dynamic regions contribute both to immune evasion/recognition and enable conformational changes required during infection. As such it remains a prime target for antiviral development efforts against common cold viruses caused by HRVs.
Inhibits virus uncoating by stabilizing capsid conformation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rhinovirus Capsid Protein VP1 (VP1).